More than 50 years of landmark results

Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.

Solutions for Complex Cases

Antitrust

Commodities

Data Privacy

Health Care

Securities

Professional Recommendations

“[Lowey Dannenberg] has considerable experience in litigating ‘some of the largest class actions throughout the country.’ . . . . The quality of their representation is also evidenced by the fact that Class Members, including sophisticated institutional investors, have not objected to the Settlement. The Court has no reason to doubt the quality of their representation.”

Hon. Gregory H. Woods, July 7, 2022 Fairness HearingTranscript, at p. 24 in In re JPMorgan Precious Metals Spoofing Litigation 18 Civ. 10356 (S.D.N.Y.)

“The court appreciates class counsel’s taking on these challenges and class counsel’s able navigation of these hard problems, in developing the case on behalf of the putative class, and in bringing contentious settlement negotiations to a successful outcome.

I might add too that the settlement was not only successful. Compared with many analogous cases, it was also prompt, a fact that brings obvious advantages to the class.”

Hon. Paul Engelmayer, May 31, 2022 Fairness Hearing Transcript, at p. 30 in In re JPMorgan Treasury Spoofing Litigation, 20 Civ. 3515 (S.D.N.Y.)

Recent Cases

Doe v. Favor, Inc., 3:23-00059 (N.D. Cal.).

Data Breach and Privacy, Data Privacy

By Christian Levis

Lowey Dannenberg represents a class of Favor (formerly Pill Club) website and app users alleging their personal data, including prescription information relating to birth control and Plan B, were unlawfully […]

Read More

Doe. v. Good Rx Holdings, Inc., No. 3:23-cv-00501-AMO (N.D. Cal.)

Data Privacy

By Christian Levis

Lowey serves as interim co-lead class counsel on behalf of Plaintiffs and Class members alleging that advertisers Google, Meta, and Criteo unlawfully intercepted GoodRx users’ medical information, including prescription information, as a result of GoodRx’s incorporation of its co-defendants’ tracking […]

Read More

In re Granulated Sugar Antitrust Litig., No. 24-mdl-3110

Commodities

By Vincent Briganti

In Sugar, plaintiffs allege a price fixing and information exchange conspiracy against the largest Sugar producers in the United States. The Court held that our pleadings survived Twombly on both […]

Read More

News

FTC Sues GoodRx for Sharing Health Data

Feb 6, 2023

On February 1, 2023, the Federal Trade Commission (“FTC”) filed a first-of-its-kind enforcement action against GoodRx alleging unfair and deceptive business practices and violations of the Health Breach Notification Rule (“HBDNR”).[1] The FTC alleged GoodRx shared…

Blog

Admissions of Guilt in SEC Settlements

Jan 4, 2022

On December 17, 2021, the SEC announced a $125 million settlement with JPMorgan Chase & Co., Disposing of allegations that the bank failed to properly monitor and retain its employees’ work-related communications.[1] Pursuant to the settlement, JPMorgan admitted to the charges—the first…

Have a Case You Think We Can Help With?

Get Our Newsletter